Webinar on

Vaccine Research & Development

Vaccine R&D 2020

Theme: Leading-edge research and In-sights of Vaccine

Meetings International has taken an initiative to felicitate attendees with awards to recognise, celebrate and encourage achievement in its various conferences and events. The Excellence Awards is organized with the intention of valuing one’s contribution to the field and behind the idea of encouraging for more active involvement for the betterment of the industry as a whole. The concept shall motivate you to achieve more which will in turn benefit the industry and could lead towards a policy implementation in nurturing for a fruitful tomorrow.

Outstanding Speaker in Vaccine R&D 2020:

This award recognizes academic and business speakers for their excellent presentation skills. Our Vaccine R&D congress encourages young scientists, researchers, doctors across the globe to take part this prestigious event and the award will be given by session chair and co-chair.

Best Key Note Speaker Vaccine R&D 2020:

This award recognises the notable presentations given during the course of the event. It also recognizes the enthusiasm and determination of the speaker to improve the experience of all who they come into contact with. The award will be given based on the impact of presentation on the attendees of the  Vaccine R&D Event. We will also be taking into account the references taken from the citations of the keynote speaker. This awardee will be felicitated by one of the members of the organizing panel present during the conference.

Best Organising Committee Member Vaccine R&D 2020:

This award seeks to recognise the continuous support provided by the Organising Committee Member of the conference. Recipient of this award will be selected by the operating committee of the  Vaccine R&D Conference. The award will be given based on the support and cooperation provided by a member of the organizing panel from the beginning to the successful completion of the conference.

Outstanding Masters/Ph.D/PostDoc Thesis work presentation in Vaccine R&D 2020:

This award seeks to recognise the young brains of the current era. Recipient of this award will be selected by the judge of the Young Researchers Forum. Participants pursuing Masters, PhD or Post-Doctoral studies are eligible for this award. The Best YRF Award will be given to the most outstanding presentation presented by a participant who has registered under the student category.

Best Poster Vaccine R&D 2020:

In order to identify best poster presentation from the poster session, conference organizing committee has appointed conference chair to evaluate the poster session,  Vaccine R&D Conference Chair decides which poster presentation will receive the Best Poster Presentation Award.

We are delighted to welcome the participants from all over the world to be a part of “Webinar on Vaccine Research & Development” scheduled in Madrid, Spain during November 25-26, 2020. A leading forum for microbiologists, researchers, scientists, elite professors, technologists and students provides the ideal environment to spread and gain current knowledge in this field. The main theme of the webinar is “Leading-Edge Research and In-Sights of Vaccine” Vaccine R&D Webinar brings upon an incipient platform to share and discuss all the innovations and potential benefits and limitations of vaccines in preventing and control of diseases. This Vaccine R&D 2020 Online Conference is confident that it will definitely offer all participants an unforgettable experience in exploring new opportunities.

Session 1: Vaccine Research & Development

Vaccine development put through a lengthy, rigorous process of scientific evaluation before licensed for general use but the process is time-consuming. The clinical trials in which vaccines are evaluated ensure that licensed vaccines are safe, effective, and suitable to use. In the past years, vaccine development did the unparalleled Ebola disease outbreak galvanized research and response, as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. The present structure for developing, testing, and regulating vaccines developed in the 20th century as the groups involved standardized their process and regulations. The Vaccine R&D conference discusses the topics related to vaccination and immunology.

Vaccine R&D Conferences | Vaccine R&D Meetings | Vaccine R&D Congress | Vaccine R&D Workshop | Vaccine R&D Events | Vaccine R&D Symposium | Vaccine R&D Convocation | Vaccine R&D Summit

Session 2: Vaccine and Types

Vaccines contain an active component i.e., an antigen that produces the protective immune response. These vaccines are of two types live or inactivate. Live, attenuated vaccines consist of ‘wild’ viruses or a bacterium that has been weakened in the lab so it can’t cause disease. Because live, attenuated vaccines are natural infection, these vaccines are “teachers” of the immune system. Whereas inactivate vaccines are created by wild viruses or bacteria that have been grown in a culture medium and inactivated before being included in a vaccine. Inactivate toxins for bacterial diseases cause illness, or merely segments of the pathogen this includes both subunit and conjugate vaccines.

Vaccine R&D Meetings | Vaccine & Vaccinology Congress | Vaccine R&D Workshop | Vaccinology R&D Events | Vaccine R&D Symposium | Vaccine R&D Convocation | Vaccine R&D Summit | Vaccine R&D Conferences

Session 3: Veterinary Vaccine

The major aims of the Vaccine Conference on veterinary vaccines are to enhance the health and welfare of animals. Vaccination of creatures is utilized both to keep their contracting sicknesses and to counteract transmission of illness to humans. Both creatures that kept as pets and creatures raised as domesticated animals are routinely immunized to prevent infections transmitted from wild categories. In a few cases, wild populations might be inoculated. While it is the case of transmitted diseases and zoonotic diseases. These veterinary vaccines have an impact not only on animal health but also on human health through preventing animal-to-human transmission of infectious diseases. The constant relation between human and animal researchers will be of major importance in finding new technologies. There are several vaccines are available and research going on in the development of several veterinary vaccines i.e. rabies, canine distemper, canine parvovirus, irresistible canine hepatitis, adenovirus-2, leptospirosis, brocatelle, canine Parainfluenza infection, and Lyme ailment, and others.

 Vaccine & Therapeutics Meetings | Vaccine & Vaccinology Congress | Vaccine R&D Workshop | Vaccinology R&D Events | Vaccine R&D Conferences | Vaccine R&D Symposium | Vaccine R&D Convocation | Veterinary Vaccine Summit

Session 4: Vaccination during Pregnancy

Vaccinating the mother before, during and after the pregnancy does not only protect the mother, it will also protect the baby’s health. A risk to a developing fetus from vaccination of the mother during pregnancy is theoretical. No evidence exists of risk to the fetus from vaccinating pregnant women with inactivated virus or bacterial vaccines or toxoids. Pregnant mothers should not take live vaccines, such as Hepatitis B vaccine, polio vaccine, rabies and rotavirus vaccine; because there's a slight chance these will harm the unborn baby. During pregnancy tetanus/diphtheria/pertussis (Tdap) is recommended, preferably between 27 and 36 weeks gestation, to protect baby from whooping cough.

Vaccine R&D Summit | Vaccine & Therapeutics Meetings | Vaccine & Vaccinology Congress | Vaccine R&D Workshop | Vaccinology R&D Congress | Vaccine R&D Conferences | Vaccine R&D Symposium | Hepatitis Vaccine Convocation

Session 5: Vaccination for Children

Vaccination given to children is called childhood Immunization. There are several vaccines for infants, newborn and a small child’s up to 6 years so nowadays vaccination for babies are mandatory until unless the child has special circumstances, like a compromised immune system or a neurological disorder all these precautionary steps are explained briefly on Vaccine Conference. In society, we can see most of the children are facing some immune disorders. Epidemics of many preventable diseases could return without vaccines, resulting in increased and unnecessary disability, illness and death among children. That is why it’s important that children, especially infants and young children receive recommended immunizations on time.

Child Vaccine R&D Meetings |  Vaccine R&D Workshop | Vaccinology R&D Events | Vaccine R&D Symposium | Vaccine & Vaccinology Congress | Vaccine R&D Convocation | Vaccine R&D Summit | Childcare Vaccine R&D Conferences

Session 6: Cancer Vaccine

Vaccines are stated to healthy people to help prevent infections, such as measles and chickenpox. These vaccines use weakened or killed germs like viruses or bacteria to start an immune response in the body. Most of the cancer vaccines work the same way, but they make the person’s immune system attack cancer cells. Cancer treatment vaccines are different from the vaccines that work as opposed to viruses. These vaccines try to get the immune system to attack cancer cells in the body. Some cancer therapy vaccines are made up of cancer cells and parts of cells, or pure antigens. Sometimes a patient’s own immune cells are detached and exposed to these substances in the lab to create the vaccine. Once the vaccine is ready, it is injected into the body to increase the immune response against the cancer cells. Cancer vaccines cause the immune system to attack cells with one or more specific antigens. The immune system contains special cells for memory, it’s hoped that the vaccine might continue to work long after it’s given.

Vaccine R&D Meetings | Vaccine & Cancer Medication Congress | Vaccine R&D Conferences | Vaccine R&D Workshop | Vaccinology R&D Events | Vaccine R&D Meet | Vaccine R&D Convocation | Vaccine R&D Summit

Session 7: HIV and AIDS vaccine

Vaccine for AIDS does not yet exist, but efforts to develop a vaccine against HIV are going on. At present there are no restorative HIV immunizations affirmed by FDA, the virus that causes AIDS, have been underway for many years. CD4 cells are a type of lymphocyte, these play an important part in the immune system. HIV vaccine would play a powerful role in ensuring the end of the AIDS epidemic. The “therapeutic” vaccine would not stop the infection, but it may prevent or delay illness in people who do become infected and might also reduce the risk of transmitting the virus to other people. The idea behind all HIV vaccines is to encourage the human immune system to fight HIV and all discussed in Vaccine Meeting.

HIV Immunization Meetings | HIV Vaccine & Vaccinology Conferences | Vaccine R&D Workshop | Vaccinology R&D Events | Vaccine R&D Symposium | Vaccine R&D Convocation | Vaccine R&D Summit | Vaccine R&D Congress

Session 8: HPV vaccine

The vaccine protects against the human papillomavirus (HPV). If the virus is long-lasting in the organs it leads to some types of cancers. The United States FDA has approved the HPV vaccine to prevent cervical, vaginal and vulvar cancer. Sexually transmitted HPV infections are common and asymptomatic, untreated cases in women are the main cause of cervical cancer. The HPV vaccine is recommended for young women through age 26 and for young men through age 21. It is important to take the HPV vaccine for teenagers. Vaccine congress gives a brief idea on the HPV vaccine.

Vaccine R&D Congress | HPV Vaccine R&D Meetings | Vaccine R&D Conferences | Vaccinology R&D Workshop | Vaccine R&D Events | Vaccine R&D Symposium | Vaccine R&D Convocation | Vaccine Medication Summit

Session 9: Production and Effectiveness of vaccine

Vaccine Conference states that Vaccine production has some stages. The manufacturing process of the vaccine has these steps Inactivation, Purification, Formulation. First, the antigen itself is generated. Viruses are grown either on a single cell i.e. on chicken eggs. The microorganisms are grown in bioreactors. Likewise, a recombinant protein derived from the viruses or microorganism can be generated in yeast. After the antigen is generated it is isolated from the cell by inactivating the virus. Recombinant proteins need many operations concerning ultrafiltration and column chromatography to be purified, and preservatives allow using multidose vials as Aggregate vaccines are more difficult to broaden and bring.

Vaccine R&D Workshop | Vaccine R&D Meetings | Vaccine R&D Events | Vaccine R&D Congress | Vaccine R&D Conferences | Vaccine R&D Events | Vaccine R&D Symposium | Vaccine R&D Convocation

Session 10: Immunology of Infectious diseases

Research in laboratories is primarily focused on infectious diseases recently in developing countries. Currently, immune-mediated and infectious disease includes HIV/AIDS, Tuberculosis, Malaria, Pneumonia, Enteric Diseases, and Autoimmune diseases. Infectious diseases are contagious diseases caused by pathogenic microorganisms. The basic pathogenic mechanisms leading to the development of advanced diagnostic tools and vaccines used in the prevention and control of infection and the identification of new targets for antiviral and anti-parasitic drugs. Pathogens inhibit the functioning of cytokines mechanisms and arrest immune recognition of infected cells. Natural killer cells are important for eliminating cells infected by the virus, and by anti-HIV immunity.

Vaccine & Vaccination Congress | Vaccine R&D Meetings | Vaccine R&D Events | Vaccine R&D Workshop | Vaccine R&D Conferences | Vaccine R&D Events | Vaccine R&D Symposium | Vaccine & vaccinology Conferences

Session 11: Vaccines for unconventional diseases

Vaccination against infectious diseases are very common but now a days antibody-inducing vaccines are introduced which can direct against non-infectious diseases and some unconventional indications vaccines against cancer, allergy, autoimmune diseases. These vaccines are introduced far before. But still, in promising late-stage with some exceptional failures, there is still no counteracting agent prompting immunization other than microorganism antigens i.e. focusing on self-antigens, enslavement atoms antigens and others. Several clinical trials may have given us a golden fruit soon on this research. Vaccines for unconventional diseases are explained briefly in the Vaccine conference.

Vaccine R&D Meetings | Vaccine R&D Events | Vaccine R&D Workshop | Vaccine & Vaccination Conferences | Vaccine R&D Congress | Vaccine R&D Events | Vaccine R&D Symposium | Vaccination & vaccinology Meet

Session 12: Vaccines Experimentation

All vaccination candidates must be put through an extended, exhaustive methodology of legitimate appraisal before they can be approved for general use. This technique is dreary – it can take up to 10 years just to move a confident vaccination through the three times of clinical progression alone. Nevertheless, it is furthermore basic. The clinical preparatory in which antibodies are surveyed ensure that approved vaccines are shielded, great, and fitting for the masses bound to use them. IAVI investigators have broad inclusion in associated examine for counteracting agent plot, the elucidation of vaccination thoughts into testable things, and the appraisal of such vaccination rivals in starting period clinical preliminaries.

Vaccine R&D Convocation | Vaccination & vaccinology Meet | Vaccine R&D Events | Vaccine R&D Workshop | Vaccination R&D Conferences | Vaccine R&D Congress | Vaccine R&D Summit | Vaccine R&D Symposium

Session 13: Poultry Vaccine

Vaccination has a fundamental impact on the prosperity organization of the poultry surge. There are different infections that are kept away from by vaccinating the flying animals against them. A vaccination keeps a particular ailment by enacting or boosting the winged creature's resistant structure to make vaccines that consequently fight the assaulting causal animals. A trademark interruption that truly causes the affliction will have an unclear result from the fowl will make antibodies that fight the present assault and furthermore to hinder future assaults by the same causal living things. Desolately flying animals that breeze up tainted by and large advance toward getting to be unthrifty, non-gainful or even fail horrendously. Pollution caused by trademark assault will be uncontrolled and in this way has the probability of causing genuine mischief; anyway, vaccination gives a technique for controlling the result with inconsequential harm to the flying animals.

Vaccine R&D Summit | Vaccinology R&D Symposium | Vaccination & vaccinology Meet | Vaccine R&D Events | Vaccine R&D Workshop | Vaccination R&D Conferences | Vaccine R&D Congress | Vaccine R&D Symposium

Session 14: Vaccines against Drugs

Internationally, drug addiction is a serious issue. The treatment being considered is vaccines against medications of mishandling. The vaccines got against the medication can take up the medication and turn away it from achieving the reward focus in the cerebrum. Barely any such antibodies have entered clinical preliminaries, however, explore is going on rapidly: Nicotine immunization, Morphine and heroin immunizations, Drug particles and insusceptible framework, Linkage science, adjuvants and immunological proteins, Cocaine immunizations.

Vaccine R&D Convocation | Vaccination R&D Symposium | Vaccination & vaccinology Meet | Vaccine R&D Congress | Vaccine R&D Workshop | Vaccine & Vaccinology Meet | Vaccine R&D Congress | Vaccine Drugs Summit

Market Analysis:

International Conference on Vaccines and Immunization is the best stage where you can consider the novel techniques to prevent diseases and expanding insusceptibility levels. This conference had particularly done with the diverse themes like bacterial immunizations, viral vaccines, travel and palatable immunizations and so on and cardiovascular immunopathy, neurological and respiratory immunopathology and so forth with various sessions. Vaccine R&D conference-2020 invites Young researchers at each profession stage to submit abstracts and announcing their recent logical discoveries and research in immunization and vaccination in oral and publication sessions. The congress will incorporate welcomed speakers, oral introductions, notice session and the youthful researcher grant.

Scope and Importance:

Vaccinology and Immunology meeting unites the Global pioneers in Immunology and significant fields to introduce their examination at this elite logical program. The Vaccine Conference facilitating introductions from editors of conspicuous alluded diaries, prestigious and dynamic agents and leaders in the field of Immunology and vaccinology. Vaccination is a key to destroy the illnesses. It is a subject for the experts who looks past the clinical prospects. Vaccinology is a noteworthy field in destruction of ailments. Conventional ways to deal with antibody configuration were to inactivate the human pathogen or a related creature homologue, Vaccinology is the study of vaccine and how the safe framework reacts to immunizations, yet furthermore incorporates ceaseless assessment of vaccination projects and immunization wellbeing and viability, and observation of the study of disease transmission of immunization preventable illnesses. This part gives a concise review of a portion of the fundamental ideas of immunology and Vaccination.

Why Prague | Czech Republic:

The help of innovative work (R&D) is one of the Government's needs in the Czech Republic. The help of Vaccine R&D was at CZK (Czech Currency) 9.67 billion out of 1999 and has expanded to the current CZK 23 billion amid the most recent 10 years, which is an expansion of 238%. Estimated by the offer of GDP, we moved from 0.52% of every 1999 to 0.62% of every 2008, which is the normal accomplished by the EU-27. Notwithstanding this unquestionable positive pattern, the required for the development of the R&D standard and better utilization of its outcomes is apparent. The advantages for economy and society remain generally low in the Czech Republic. In some regard, it is a result of the present arrangement of R&D open help, which is somewhat decentralized. On a fundamental level, all Ministries and Central Administrative Authorities bolster R&D from their own financial plan.

Vaccine Markets in Eastern Europe to 2022:

The report bundle Vaccine Markets in Eastern Europe to 2022 offers the most progressive industry information on the real market circumstance and future viewpoint for antibodies in various Eastern European nations. The bundle incorporates nation reports from the accompanying nations: Armenia, Bosnia Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey and Ukraine. The exploration incorporates authentic information from 2011 to 2017 and gauges until the point when 2022 which makes the reports a precious asset for industry administrators, promoting, deals and item chiefs, specialists, investigators, and other individuals searching for entering industry information in promptly available records with unmistakably exhibited tables and charts.

Market outlook of the global vaccine market:

The vaccine showcase is relied upon to achieve USD 49.27 Billion by 2022 from USD 34.30 Billion out of 2017, at a CAGR of 7.5%. The development of the market is ascribed to the rising pervasiveness of ailments, expanding government and nongovernment financing for vaccine advancement, and expanding ventures by organizations.

More up to date and more costly vaccines are coming into the market speedier than at any other time. Vaccine improvement: expanding speculation. Tripled in an incentive from USD 5B out of 2000 to nearly USD 24 B in 2013 – Influenza antibody showcase: assessed at $2.9 billion of every 2011 to $3.8 billion by 2018 – US: $1.6 billion of every 2011 to $2.2 billion out of 2018. The worldwide market anticipated ascending to USD 100 B by 2025. More than 120 new items in the advancement pipeline. Changing the status of the immunizations inside the pharmaceutical business. New plan of action for vaccines is rising.

The vaccines market is highly competitive with the presence of various players. Some of the major players operating in the market are GlaxoSmithKline, plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), and Panacea Biotec (India).

Associations & Societies Associated with Vaccines:

• The Lancet Infectious Diseases

• European Respiratory Society (ERS)

• European Society for Paediatric Infectious Diseases (ESPID)

• Global Chinese Association of Clinical Microbiology and Infectious Diseases (GCACMID)

• Infectious Diseases Society of America (IDSA)

• International Society of Chemotherapy (ISC)

• Infectious Diseases Society of America

• International Society for Infectious Diseases (ISID)

• International Society of Chemotherapy, Infection and Cancer

• Federation of Immunological Societies of Asia-Oceania

• The International Society for Interferon and Cytokine Research, USA

• Federation of Clinical Immunology Societies, USA

• European Society of Gene Therapy, Germany

Universities associated with vaccines:

• University of Bath, UK

• American College Health Association (ACHA) Hanover, Maryland

• The College of Physicians of Philadelphia, US

• Erasmus University Rotterdam, Netherland

• University of BERN, Switzerland

• University of Cambridge

• University of Oxford

• The University of Sydney

• Johns Hopkins University

• Saba University School of Medicine, Netherlands

• University of Minho, Portugal

• Medical University of Lublin, Poland

Global Funding Bodies:

• United Nations Children’s Fund (UNICEF)

• Global Alliance for Vaccines and Immunization (GAVI)

• Rockefeller Foundation (RF)

• Centre for Disease Control and Prevention (CDC)

• Bill and Melinda Gates Foundation

• American Academy of Paediatrics (AAP)

• Vaccine Foundation (V Foundation)

• National Institute of Health (NIH)

• Children’s Vaccine Initiative (CVI)

• Center for Infectious Disease Research and Policy (CIDRAP).

Conclusion

Vaccines are necessary — and good hygiene, sanitation, clean water, and nutrition are insufficient for stopping infectious diseases. If we don’t maintain optimum rates of immunization or “herd immunity”, the diseases prevented by vaccination will return. While better hygiene, sanitation and clean water help protect people from infectious diseases, many infections can spread regardless of how clean we are. If people are not vaccinated, diseases that have become uncommon such as pertussis (whooping cough), polio and measles, will quickly reappear.

Meetings International is announcing Young Scientist Awards through 4th International Congress on Vaccine R&D (Vaccine Research 2020) which is scheduled at Madrid, Spain during November 23-24, 2020. This Vaccine Research 2020 focuses on “Leading-Edge Research and In-Sights of Vaccine”.

Vaccine Research 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Vaccine Research 2020 focuses mainly on Vaccine Research & development, Vaccine and Types, Veterinary Vaccine, Vaccination for Children, Cancer Vaccine, HIV & AIDS Vaccine. 4th International Congress on Vaccine R&D is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Recycling Conference.

When you want to be noticed with the content that counts, advertise with Meetings International and reach minds that matter. Meetings International is a global leader in producing high quality conferences and workshops in all major fields of science, technology and medicine.

Meetings International Conference websites are being visited by doctors, engineers, young and budding researchers, entrepreneurs, eminent scientists, academicians and Nobel laureates from various sectors of medical and non-medical sciences. We can target impressions of your advertisements by conferences subject or region and report results in comprehensive detail.

4th International Vaccine R&D Congress encourages various companies and small-scale business to digitally advertise their products and services on its web platform which will definitely help in informing and attracting new customers quickly and efficiently. The size and diversity of our advertising options provide clients with the very best customized marketing opportunities. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.

If you are looking for a global exposure for your products and services, this is the right place for you. Display advertising improves the visibility of your products and services among specialists in your field. Bring your product to life and create instant brand awareness with a banner ad placement. Make your banner interactive to direct people to where you want them to go. We offer banner ads on our website which will be beneficial for healthcare professionals across the globe.

Our subscribers and conference attendees can be your upcoming enthusiastic customers. If you sell vaccine products or provide relevant services, here is your opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide.

Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

In case you have any queries regarding advertising opportunities, please contact our representative: contact@meetingsint.com

  • Vaccine Research & Development
  • Vaccine and Types
  • Veterinary Vaccine
  • Vaccination for Children
  • Cancer Vaccine
  • HIV and AIDS vaccine
  • Production and Effectiveness of vaccine
  • Immunology of Infectious diseases
  • Vaccines Experimentation
  • Poultry Vaccine

3 Organizing Committee Members

OCM Member
Ahmed G. Hegazi

Professor
National Research Center
Egypt

OCM Member
Ian J Martins

Fellow of International Agency for Standards and Ratings (IASR)
Edith Cowan University
Australia

OCM Member
Giulio Tarro

Professor
Naples University
Italy

More...

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner